Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ)
CNY 13.18
(1.07%)
CNY 13.18
(1.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 824.69 Million | 855.77 Million | 365.02 Million | 513.21 Million | 535.3 Million | 523.4 Million |
| Net Income | 618.89 Million | 667.82 Million | 614.7 Million | 653.32 Million | 521.94 Million | 371.48 Million |
| Depreciation & Amortization | 221.46 Million | 166.87 Million | 143.55 Million | 123.2 Million | 106.2 Million | 90.57 Million |
| Deferred income taxes | 2.83 Million | -12.21 Million | -5.75 Million | 31 Million | -139.01 Thousand | -9.86 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -45.01 Million | 21.34 Million | -391.74 Million | -120.91 Million | -42.26 Million | 97.51 Million |
| Other non-cash items | 514.45 Million | -263.49 Thousand | -1.48 Million | -142.4 Million | -50.58 Million | -36.17 Million |
| Investing Cash Flow | -769.44 Million | -737.65 Million | 144.68 Million | 463.92 Million | -214.2 Million | -172.19 Million |
| Investments in PPE | -519.51 Million | -515.57 Million | -404.43 Million | -334 Million | -337.33 Million | -242.19 Million |
| Acquisitions | 10.26 Million | 5.21 Million | 8.25 Million | 2.44 Million | -1.86 Million | - |
| Investment purchases | -1.17 Billion | -1.05 Billion | -861.66 Million | -2.17 Billion | -2.14 Billion | -2.85 Billion |
| Sales/Maturities of investments | 915 Million | 833.94 Million | 1.4 Billion | 2.97 Billion | 2.26 Billion | 2.92 Billion |
| Other Investing Activities | -1.00 | -3.22 Million | -5.33 Million | -12.5 Million | 2.5 Million | 2.75 Million |
| Financing Cash Flow | -245.6 Million | -188.03 Million | 120.84 Million | -497.37 Million | -226.34 Million | -278.04 Million |
| Debt repayment | -35 Million | -150 Million | -300.32 Million | -358.75 Million | -155 Million | -143.23 Million |
| Dividends payments | -258.3 Million | -258.3 Million | -231.42 Million | -231.94 Million | -205.84 Million | -142.81 Million |
| Common Stock Repurchased | - | - | - | -200.98 Million | -235.51 Million | -267.4 Million |
| Common Stock Issuance | - | - | - | 200.98 Million | 49.29 Million | 9 Million |
| Other Financing Activities | -3.96 Million | 220.52 Million | 653.33 Million | 96.79 Million | 321.79 Million | -135.23 Million |
| Accounts receivables | -93.47 Million | -250.89 Million | -208.58 Million | 34.44 Million | -170.3 Million | -136.63 Million |
| Accounts payables | -74.58 Million | 387.4 Million | -41.84 Million | -103.67 Million | 188.29 Million | 313.28 Million |
| Inventory | 123.04 Million | -102.95 Million | -147.79 Million | -82.69 Million | -60.12 Million | -68.74 Million |
| Other working capital | 1.00 | -12.21 Million | 6.47 Million | 31 Million | -139.01 Thousand | 166.26 Million |
| Cash at beginning of period | 1.48 Billion | 1.51 Billion | 886.02 Million | 416.21 Million | 319.68 Million | 242.91 Million |
| Cash at end of period | 1.41 Billion | 1.46 Billion | 1.51 Billion | 886.02 Million | 416.21 Million | 319.4 Million |
| Capital Expenditure | -519.51 Million | -515.57 Million | -404.43 Million | -334 Million | -337.33 Million | -242.19 Million |
| Effect of forex changes on cash | 2.71 Million | 14.86 Million | -3.75 Million | -9.94 Million | 1.78 Million | 3.33 Million |
| Net cash flow / Change in cash | -77.83 Million | -55.04 Million | 626.8 Million | 469.81 Million | 96.53 Million | 76.49 Million |
| Free Cash Flow | 305.17 Million | 340.2 Million | -39.41 Million | 179.2 Million | 197.96 Million | 281.21 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 172.89 Million | 230.91 Million | 171.2 Million | 618.89 Million | 146.27 Million | 156.69 Million |
| Depreciation & Amortization | - | 75.64 Million | - | 221.46 Million | 57.88 Million | -100.98 Million |
| Deferred income taxes | - | - | - | 2.83 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -160.07 Million | - | -45.01 Million | 29.56 Million | 115.56 Million |
| Other non-cash items | -30 Million | -31.81 Million | 185.09 Million | 514.45 Million | 63.19 Million | -83.99 Million |
| Investing Cash Flow | -274.34 Million | -1.55 Billion | 295.29 Million | -769.44 Million | -141.88 Million | -252.07 Million |
| Investments in PPE | -42.79 Million | -61.47 Million | -77.47 Million | -519.51 Million | -76.54 Million | -94.07 Million |
| Acquisitions | 1.73 Million | -333.34 Thousand | 400 Thousand | 10.26 Million | 4.68 Million | 429.19 Thousand |
| Investment purchases | -1.98 Billion | -2.52 Billion | -110 Million | -1.17 Billion | -205.02 Million | -365.17 Million |
| Sales/Maturities of investments | 1.75 Billion | 1.03 Billion | 482.77 Million | 915 Million | 135 Million | 206.73 Million |
| Other Investing Activities | 1.33 Million | 2.4 Million | 372.77 Million | -1.00 | -60.79 Million | 0.03 |
| Financing Cash Flow | -62.27 Million | -141.86 Million | 48.66 Million | -245.6 Million | -84.45 Million | -2.18 Million |
| Debt repayment | -60.63 Million | -128.47 Million | -49.71 Million | -35 Million | -80.89 Million | -150 Million |
| Dividends payments | - | -258.3 Million | - | -258.3 Million | -258.3 Million | -0.03 |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.64 Million | -260.01 Million | -1.04 Million | -3.96 Million | 273.08 Million | 147.81 Million |
| Accounts receivables | - | -111.44 Million | - | -93.47 Million | -93.47 Million | 102.43 Million |
| Accounts payables | - | - | - | -74.58 Million | - | - |
| Inventory | - | -48.63 Million | - | 123.04 Million | 123.04 Million | 13.13 Million |
| Other working capital | - | - | - | 1.00 | - | - |
| Cash at beginning of period | 408.16 Million | 2.06 Billion | 1.27 Billion | 1.48 Billion | 1.24 Billion | 1.37 Billion |
| Cash at end of period | 204.18 Million | 459.58 Million | 1.97 Billion | 1.41 Billion | 1.41 Billion | 1.2 Billion |
| Capital Expenditure | -42.79 Million | -61.47 Million | -77.47 Million | -519.51 Million | -76.54 Million | -94.07 Million |
| Effect of forex changes on cash | -3.88 Million | 2.15 Million | 1.33 Million | 2.71 Million | 270.18 Thousand | 761.86 Thousand |
| Net cash flow / Change in cash | -203.98 Million | -1.61 Billion | 698.82 Million | -77.83 Million | 167.56 Million | -166.21 Million |
| Free Cash Flow | 100.08 Million | 61.97 Million | 278.82 Million | 305.17 Million | 220.37 Million | -6.78 Million |
BKMM
TYX
033250
APEX
000816
BIRD